Cargando…
Blood Biomarker Panels for the Early Prediction of Stroke‐Associated Complications
BACKGROUND: Acute decompensated heart failure (ADHF) and respiratory tract infections (RTIs) are potentially life‐threatening complications in patients experiencing stroke during hospitalization. We aimed to test whether blood biomarker panels might predict these complications early after admission....
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174272/ https://www.ncbi.nlm.nih.gov/pubmed/33634708 http://dx.doi.org/10.1161/JAHA.120.018946 |
_version_ | 1783702872597200896 |
---|---|
author | Faura, Júlia Bustamante, Alejandro Reverté, Silvia García‐Berrocoso, Teresa Millán, Mónica Castellanos, Mar Lara‐Rodríguez, Blanca Zaragoza, Josep Ventura, Oriol Hernández‐Pérez, María van Eendenburg, Cecile Cardona, Pere López‐Cancio, Elena Cánovas, David Serena, Joaquín Rubiera, Marta Dávalos, Antoni Montaner, Joan |
author_facet | Faura, Júlia Bustamante, Alejandro Reverté, Silvia García‐Berrocoso, Teresa Millán, Mónica Castellanos, Mar Lara‐Rodríguez, Blanca Zaragoza, Josep Ventura, Oriol Hernández‐Pérez, María van Eendenburg, Cecile Cardona, Pere López‐Cancio, Elena Cánovas, David Serena, Joaquín Rubiera, Marta Dávalos, Antoni Montaner, Joan |
author_sort | Faura, Júlia |
collection | PubMed |
description | BACKGROUND: Acute decompensated heart failure (ADHF) and respiratory tract infections (RTIs) are potentially life‐threatening complications in patients experiencing stroke during hospitalization. We aimed to test whether blood biomarker panels might predict these complications early after admission. METHODS AND RESULTS: Nine hundred thirty‐eight patients experiencing ischemic stroke were prospectively recruited in the Stroke‐Chip study. Post‐stroke complications during hospitalization were retrospectively evaluated. Blood samples were drawn within 6 hours after stroke onset, and 14 biomarkers were analyzed by immunoassays. Biomarker values were normalized using log‐transformation and Z score. PanelomiX algorithm was used to select panels with the best accuracy for predicting ADHF and RTI. Logistic regression models were constructed with the clinical variables and the biomarker panels. The additional predictive value of the panels compared with the clinical model alone was evaluated by receiver operating characteristic curves. An internal validation through a 10‐fold cross‐validation with 3 repeats was performed. ADHF and RTI occurred in 19 (2%) and 86 (9.1%) cases, respectively. Three‐biomarker panels were developed as predictors: vascular adhesion protein‐1 >5.67, NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) >4.98 and d‐dimer >5.38 (sensitivity, 89.5%; specificity, 71.7%) for ADHF; and interleukin‐6 >3.97, von Willebrand factor >3.67, and d‐dimer >4.58 (sensitivity, 82.6%; specificity, 59.8%) for RTI. Both panels independently predicted stroke complications (panel for ADHF: odds ratio [OR] [95% CI], 10.1 [3–52.2]; panel for RTI: OR, 3.73 [1.95–7.14]) after adjustment by clinical confounders. The addition of the panel to clinical predictors significantly improved areas under the curve of the receiver operating characteristic curves in both cases. CONCLUSIONS: Blood biomarkers could be useful for the early prediction of ADHF and RTI. Future studies should assess the usefulness of these panels in front of patients experiencing stroke with respiratory symptoms such as dyspnea. |
format | Online Article Text |
id | pubmed-8174272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81742722021-06-11 Blood Biomarker Panels for the Early Prediction of Stroke‐Associated Complications Faura, Júlia Bustamante, Alejandro Reverté, Silvia García‐Berrocoso, Teresa Millán, Mónica Castellanos, Mar Lara‐Rodríguez, Blanca Zaragoza, Josep Ventura, Oriol Hernández‐Pérez, María van Eendenburg, Cecile Cardona, Pere López‐Cancio, Elena Cánovas, David Serena, Joaquín Rubiera, Marta Dávalos, Antoni Montaner, Joan J Am Heart Assoc Original Research BACKGROUND: Acute decompensated heart failure (ADHF) and respiratory tract infections (RTIs) are potentially life‐threatening complications in patients experiencing stroke during hospitalization. We aimed to test whether blood biomarker panels might predict these complications early after admission. METHODS AND RESULTS: Nine hundred thirty‐eight patients experiencing ischemic stroke were prospectively recruited in the Stroke‐Chip study. Post‐stroke complications during hospitalization were retrospectively evaluated. Blood samples were drawn within 6 hours after stroke onset, and 14 biomarkers were analyzed by immunoassays. Biomarker values were normalized using log‐transformation and Z score. PanelomiX algorithm was used to select panels with the best accuracy for predicting ADHF and RTI. Logistic regression models were constructed with the clinical variables and the biomarker panels. The additional predictive value of the panels compared with the clinical model alone was evaluated by receiver operating characteristic curves. An internal validation through a 10‐fold cross‐validation with 3 repeats was performed. ADHF and RTI occurred in 19 (2%) and 86 (9.1%) cases, respectively. Three‐biomarker panels were developed as predictors: vascular adhesion protein‐1 >5.67, NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) >4.98 and d‐dimer >5.38 (sensitivity, 89.5%; specificity, 71.7%) for ADHF; and interleukin‐6 >3.97, von Willebrand factor >3.67, and d‐dimer >4.58 (sensitivity, 82.6%; specificity, 59.8%) for RTI. Both panels independently predicted stroke complications (panel for ADHF: odds ratio [OR] [95% CI], 10.1 [3–52.2]; panel for RTI: OR, 3.73 [1.95–7.14]) after adjustment by clinical confounders. The addition of the panel to clinical predictors significantly improved areas under the curve of the receiver operating characteristic curves in both cases. CONCLUSIONS: Blood biomarkers could be useful for the early prediction of ADHF and RTI. Future studies should assess the usefulness of these panels in front of patients experiencing stroke with respiratory symptoms such as dyspnea. John Wiley and Sons Inc. 2021-02-26 /pmc/articles/PMC8174272/ /pubmed/33634708 http://dx.doi.org/10.1161/JAHA.120.018946 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Faura, Júlia Bustamante, Alejandro Reverté, Silvia García‐Berrocoso, Teresa Millán, Mónica Castellanos, Mar Lara‐Rodríguez, Blanca Zaragoza, Josep Ventura, Oriol Hernández‐Pérez, María van Eendenburg, Cecile Cardona, Pere López‐Cancio, Elena Cánovas, David Serena, Joaquín Rubiera, Marta Dávalos, Antoni Montaner, Joan Blood Biomarker Panels for the Early Prediction of Stroke‐Associated Complications |
title | Blood Biomarker Panels for the Early Prediction of Stroke‐Associated Complications |
title_full | Blood Biomarker Panels for the Early Prediction of Stroke‐Associated Complications |
title_fullStr | Blood Biomarker Panels for the Early Prediction of Stroke‐Associated Complications |
title_full_unstemmed | Blood Biomarker Panels for the Early Prediction of Stroke‐Associated Complications |
title_short | Blood Biomarker Panels for the Early Prediction of Stroke‐Associated Complications |
title_sort | blood biomarker panels for the early prediction of stroke‐associated complications |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174272/ https://www.ncbi.nlm.nih.gov/pubmed/33634708 http://dx.doi.org/10.1161/JAHA.120.018946 |
work_keys_str_mv | AT faurajulia bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT bustamantealejandro bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT revertesilvia bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT garciaberrocosoteresa bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT millanmonica bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT castellanosmar bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT lararodriguezblanca bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT zaragozajosep bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT venturaoriol bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT hernandezperezmaria bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT vaneendenburgcecile bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT cardonapere bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT lopezcancioelena bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT canovasdavid bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT serenajoaquin bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT rubieramarta bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT davalosantoni bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications AT montanerjoan bloodbiomarkerpanelsfortheearlypredictionofstrokeassociatedcomplications |